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https://doi.org/10.1016/j.cels.2020.04.005SUMMARYComplex networks of regulatory relationships between protein kinases comprise amajor component of intra-
cellular signaling. Althoughmany kinase-kinase regulatory relationships have been described in detail, these
tend to be limited to well-studied kinases whereas themajority of possible relationships remains unexplored.
Here, we implement a data-driven, supervisedmachine learningmethod to predict human kinase-kinase reg-
ulatory relationships and whether they have activating or inhibiting effects. We incorporate high-throughput
data, kinase specificity profiles, and structural information to produce our predictions. The results success-
fully recapitulate previously annotated regulatory relationships and can reconstruct known signaling path-
ways from the ground up. The full network of predictions is relatively sparse, with the vast majority of relation-
ships assigned low probabilities. However, it nevertheless suggests denser modes of inter-kinase regulation
than normally considered in intracellular signaling research. A record of this paper’s transparent peer review
process is included in the Supplemental Information.INTRODUCTION
Cells continually respond and adapt to environmental stimuli.
They employ sophisticated protein networks to propagate,
amplify, and subsequently quench these signals efficiently. A
common mechanism of relaying information from one protein
to another is through reversible post-translational modifications
(PTMs). Protein phosphorylation by kinases is one of the prin-
cipal and best-studied PTMs. It plays a major role in cellular pro-
cesses, such as growth, division, and differentiation (Acosta-Ja-
quez et al., 2009; Basson, 2012; Rhind and Russell, 2012).
Many protein kinases are themselves regulated by phosphor-
ylation, giving rise to complex networks of kinase-kinase regula-
tory relationships. An accumulation of biochemical knowledge
has produced consensus maps of several protein-kinase
signaling pathways, which have been deposited in databases,
such as Reactome (Fabregat et al., 2017), KEGG (Kanehisa
et al., 2017), and SIGNOR (Perfetto et al., 2016). Kinase-kinase
and other kinase-substrate relationships have also been anno-
tated in databases, such as PhosphoSitePlus and Phospho.ELM
(Dinkel et al., 2011; Hornbeck et al., 2015). However, a focus on
well-studied protein kinases in the experimental investigation of
kinase regulatory relationships overrepresents the activities of
these kinases and has left the majority of the kinase-kinase inter-
action space largely unexplored (Invergo and Beltrao, 2018).384 Cell Systems 10, 384–396, May 20, 2020 ª 2020 The Authors. Pu
This is an open access article under the CC BY license (http://creativeSimilar effects have been reported for protein-protein interaction
databases (Gillis et al., 2014). Subsequent proteome-wide ana-
lyses have found protein interactions to be ultimately more
evenly spread across the proteome than previously indicated
(Rolland et al., 2014), and the same is likely to be true for kinase
signaling.
Incomplete maps of regulatory relationships could have
serious impacts on systems-level analyses of signaling path-
ways. There is, therefore, a clear need for new methods
for finding kinase-kinase regulatory relationships. Existing
methods for data-driven reconstruction of signaling networks
are generally designed for data that have been produced for
the study of a specific pathway (e.g., via perturbation experi-
ments) and typically benefit from the incorporation of prior
knowledge about that pathway into the model (see, e.g., Hill
et al., 2016; Invergo and Beltrao, 2018). The use of incomplete
prior knowledge means that these methods are less likely to
provide insight into broader patterns of protein-kinase regula-
tion, especially of understudied kinases or cross-module
signaling. However, recent advances in high-throughput
phosphoproteomics, through liquid-chromatography tandem
mass spectrometry (LC-MS/MS) and other technologies,
show promise in the inference and analysis of signaling net-
works at larger scale (Babur et al., 2018; Rudolph et al.,
2016; Terfve et al., 2015).blished by Elsevier Inc.
commons.org/licenses/by/4.0/).
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tize future experiments. Numerous previous attempts have
been made to predict kinase-substrate relationships based
on various features, such as amino acid sequences and/or
functional information. Earlier methods, including Scansite
(Obenauer et al., 2003) and NetPhosK (Blom et al., 2004), utilize
position-specific scoring matrices (PSSMs) and neural net-
works to make predictions based on previously annotated sub-
strates. Anothermethod, GPS (group-based prediction system)
(Zhou et al., 2004) bases prediction on peptide similarities and
the Markov Cluster Algorithm. Later methods have integrated
other features, such as probabilistic networks in addition to
consensus sequences (Linding et al., 2007). Notably, however,
thesemethods are geared toward the prediction of target phos-
phosites and do not make predictions about the regulatory
impact of the phosphorylation. Some pathway reconstruction
methods, such as modular response analysis (Kholodenko
et al., 2002) or Bayesian techniques (Hill et al., 2012, 2017;
Oates and Mukherjee, 2012; Oates et al., 2014), can infer ki-
nase-kinase regulatory relationships, but they do not scale
easily for many kinases, and they require purpose-built pertur-
bation experimental data. Other methods scale to incorporate
phosphoproteomic data for generalized predictions, but they
require or benefit from the provision of a prior, literature-derived
network from which to make predictions of regulatory relation-
ships (see, e.g., Köksal et al., 2018; Rudolph et al., 2016; Terfve
et al., 2015; Wilkes et al., 2015).
Here, we propose a supervised machine learning approach to
estimate the probability of a functional, regulatory relationship
between arbitrary pairs of human kinases, as well as to predict
the sign (inhibiting or activating) of the regulation. We train the
predictions on known kinase regulatory relationships by
combining phosphoproteomic and transcriptomic data with ki-
nase-substrate-sequence specificity models and a recently pro-
duced predictor of phosphosite functional impact (Ochoa et al.,
2020). Our models allow us to make inferences even for kinases
that lack any substrate annotations. The resulting network of
predicted kinase-kinase regulatory relationships is highly
modular and partitions into several clusters that reflect known
functional associations, while suggesting denser modes of in-
ter-regulation and feedback than typically assumed.
RESULTS
Regulatory Relationships Can Be Identified by Similar
Phosphorylation Patterns at Functional Phosphosites
and by Kinase Coexpression
We assume that kinases that are activated or inhibited in the
same sets of conditions are more likely to be part of the same
pathway and could form a regulatory interaction. Because
many protein kinases are regulated by phosphorylation, we
measured the correlation of phosphorylation of regulatory phos-
phosites for pairs of kinases across different conditions. If regu-
latory sites on two kinases show similar patterns of phosphory-
lation, one of the kinases might be responsible for regulating
the other’s activity. We assessed correlations of phosphosite
quantification in two large-scale phosphoproteomic experi-
ments (Mertins et al., 2016; Wilkes et al., 2015). Given that regu-
latory phosphosites have only been established for a small sub-set of kinases, we employed a recently produced computational
predictor of phosphosite functionality (Ochoa et al., 2020). This
provided us with a score from 0.0 to 1.0 for each kinase phos-
phosite, with higher values indicating a stronger prediction of
such sites regulating the kinase activity (‘‘functional sites’’).
We found that kinase-kinase regulatory pairs often exhibit co-
phosphorylation patterns at functional phosphosites. For
example, mitogen-activated protein kinase 3 (MAPK3) is known
to regulate the activity of ribosomal protein S6 kinases (Mérienne
et al., 2000; Smith et al., 1999; Zhao et al., 1996). Indeed, we
found strong correlation between functional sites T202 on
MAPK3 and T577 on S6K-alpha-3 (RPS6KA3); meanwhile, no
such correlation was found for atypical MAPK4, which has no
known regulatory relationship with S6 kinases (Figure 1A). We
quantified this relationship for each pair of sites between two ki-
nases by producing a phosphosite ‘‘coregulation score,’’ in
which the log-transformed p value of the correlation is scaled
by the two sites’ functional scores (Figure 1A). We then checked
whether known regulatory relationships annotated in the Omni-
Path database (T€urei et al., 2016) have higher coregulation
scores than unannotated pairs. In both phosphoproteomic ex-
periments, kinase-kinase regulatory pairs tend to exhibit higher
maximum coregulation scores than pairs with no previously an-
notated relationship (one-sided Wilcoxon rank sum test, W =
2.8 3 107, p < 1 3 106 [Mertins et al., 2016]; W = 9.3 3 105,
p < 1 3 106 [Wilkes et al., 2015]) (Figure 1B).
We next used two RNA sequencing (RNA-seq) datasets (GTEx
Consortium, 2013; Uhlén et al., 2015) to test whether kinase co-
expression is indicative of regulatory relationships. For example,
if we consider the regulation of tyrosine-protein kinase BTK by
Src-family protein kinases, we see a clear positive correlation
between BTK expression and that of LYN (encoding tyrosine-
protein kinase Lyn, a known regulator) (Cheng et al., 1994;
Park et al., 1996; Rawlings et al., 1996). No such correlation ex-
ists for YES1 (tyrosine protein kinase Yes, which is not known to
regulate BTK) (Figure 1C). In general, we found higher coexpres-
sion between pairs of kinases where a regulatory relationship ex-
ists than for those without any annotated relationship in both
expression datasets (one-sided Wilcoxon rank sum test, W =
1.3 3 108, p < 1 3 106 [GTEx Consortium, 2013]; W = 1.3 3
108, p < 1 3 106 [Uhlén et al., 2015]) (Figure 1B).
We also found that tissue specificity, as represented by the
skewness of expression values across tissue samples, is further
indicative of kinase regulatory relationships. Continuing from the
previous example, we can see that BTK and LYN both have
skewed expression profiles (high expression in a few tissues),
whereas YES1 has relatively even expression across tissues
(Figure 1D). If we consider the absolute difference between tis-
sue specificities for pairs of protein kinases, we find that pairs
with regulatory relationships tend to have more similar expres-
sion profiles than those with no annotated relationship (one-
sided Wilcoxon rank sum test, W = 8.9 3 107, p < 1 3 106 )
(Figure 1B).
Linking Sequence Specificity to Phosphosite Functional
Impact Identifies Direct Regulation of Protein-Kinase
Activity
Kinases show preferences for phosphorylating some





Figure 1. Correlations in Phosphorylation at
Regulatory Sites or in Tissue Expression Pat-
terns Are Predictive of Kinase-Kinase Regu-
latory Relationships
(A) Top: kinase MAPK3 exhibits cophosphorylation
patterns at functional sites with RPS6KA3, a known
substrate. The same patterns are not observed for
MAPK4. Gray cells indicate missing values. Bottom:
combining cophosphorylation p values and site
functional scores provides an estimator of cor-
egulation.
(B) Phospho-coregulation, tissue coexpression, and
tissue specificity can discriminate cases of kinase-
kinase regulation annotated in the OmniPath data-
base from unannotated cases.
(C) The RNA transcripts encoding SRC-family ki-
nase LYN and known substrate BTK show similar
patterns of expression, while the expression of
SRC-family kinase YES1, not known to regulate
BTK, is unrelated. Shaded area represents 95%
confidence intervals.
(D) Top: kernel-density estimates of the distributions
of expression values across tissue samples forBTK,
LYN, and YES1. Bottom: tissue specificity of RNA
expression was quantified as the skewness of the
kernel-density distributions. Here, YES1 is more
broadly expressed than the tissue-specific LYN
and BTK.
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sequence. By characterizing this specificity in a PSSM, we
can score a kinase’s potential for directly phosphorylating a pu-
tative substrate. However, we also wanted to determine, in an
unbiased way, whether high-scoring substrate sites also tend
to have regulatory effects. To achieve this, we employed the
discounted cumulative gain (DCG)metric often used in the eval-
uation of information retrieval systems (J€arvelin and
Kek€al€ainen, 2002), wherein we treated a PSSM as a phospho-
site ‘‘search function’’ and the functional score as a phospho-
site ‘‘relevance metric.’’
Only 140 protein kinases had sufficient numbers of known
substrate sites to build confident PSSMs. We have recently
shown that proteins within the same kinase family tend to
show similar specificity, which can be attributed to conserved
specificity-determining residues (SDRs) within their protein-ki-
nase domains (Bradley and Beltrao, 2019; Bradley et al., 2018).
We thus investigated this as a means to assign PSSMs to ki-
nases with insufficient substrate annotations. We first estimated
theminimum residue similarity necessary across 10 kinase SDRs
to make accurate PSSM assignments. We found that an SDR
similarity of at least 0.8 (based on the BLOSUM62 amino acid
substitution matrix) is needed to make assignments that are
significantly better than a random assignment (Figure 2A).
Nevertheless, this method of assignment did not substantially
improve upon simply assigning a family-wise, composite
PSSM (Figure 2B). Based on these results, we increased the
coverage of kinases with PSSMs by assigning to under-anno-
tated kinases a family-wise PSSM, where available (n= 208),
or otherwise one via SDR similarity (n= 14), bringing the total386 Cell Systems 10, 384–396, May 20, 2020number of protein kinases with specificity profiles to 362
(Figure 2C).
Linking PSSM predictions to phosphosite functional scores
via the DCG is best illustrated by an example. RAC-alpha
serine/threonine-protein kinase (AKT1) has several phospho-
sites, a few of which have high functional scores. We consider
two potential regulators: 3-phosphoinositide-dependent protein
kinase 1 (PDPK1), a known regulator, and protein kinase C
gamma type (PRKGC), not known to regulate AKT1. Some of
AKT1’s sites with the highest functional scores also score highly
with PDPK1’s PSSM, whereas PRKCG’s PSSM favors sites with
low functional scores (Figure 2D). These relationships can be
quantified and visualized via the DCG: substrate sites are ranked
by PSSMscore and a cumulative sumof their functional scores is
calculated, wherein each successive site contributes a smaller
fraction of its functional score (Figure 2E). We can see that,
although the two protein kinases achieve similar maximum
PSSM scores, only PDPK1 produces a high DCG (Figure 2F).
As would be expected, we found that the PSSMs of known
regulators in OmniPath tend to score highly for at least one of
their substrate’s phosphosites (one-sided Wilcoxon rank sum
test, W = 1.03 108, p < 13 106 ) (Figure 2G, left). Furthermore,
simply having a substrate site with a high functional score, indi-
cating that the substrate is amenable to regulation by phosphor-
ylation, can be predictive of a regulatory relationship (one-sided
Wilcoxon rank sum test, W = 6.43 107, p < 13 106 ) (Figure 2G,
center). Linking these two metrics across all sites on the sub-
strate via the DCG, we produced a score that could discriminate
true regulatory relationships (one-sided Wilcoxon rank sum test,






































































































































max. PSSM score max. functional score DCG score
0.00 0.25 0.50 0.75 0.00 0.25 0.50 0.75 1.00 0.00 0.25 0.50 0.75 1.00
no known relationship known relationship
Figure 2. Kinase-Kinase Regulatory Relation-
ships Can Be Predicted from Sequence Speci-
ficity and Phosphosite Functional Scores
(A) Similar kinase SDRs also indicate similar PSSMs.
The red line indicates the 97.5th percentile of the dis-
tribution of distances between cross-validation
PSSMs using different subsets of a kinase’s anno-
tated substrates. At an SDR similarity of at least 0.8,
over 50% of assigned PSSMs are less than this dis-
tance from their true values.
(B) Assigning family-wise, composite PSSMs to un-
annotated kinases achieves similar, if not better, per-
formance to SDR-based assignment.
(C) Numbers of PSSMs by source (own annotations =
140, by family = 208, and by SDR similarity = 14).
(D) PSSMs locate functional sites on substrates with
differing performance. Here, the PSSM of PDPK1, a
known regulator of AKT1, scores highly for sites with
high functional scores, while that of PRKCG does not.
(E) DCG quantifies the potential for a kinase to phos-
phorylate a putative substrate at its functional sites.
(F) Although both PDPK1 and PRKCG have similar
maximum PSSM scores for phosphorylating AKT1,
only PDPK1 achieves a high DCG.
(G) Maximum PSSM score, maximum substrate-site
functional score, and DCG all discriminate regulatory
relationships annotated in the OmniPath database
from unannotated ones.
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Phosphosites that Induce or Inhibit Kinase Activity
Phosphorylation events can lead to different regulatory out-
comes for the substrate kinase, potentially inducing or inhibiting
its enzymatic activity. Knowing these regulatory effects is essen-
tial to understanding the flow of information across complex net-
works of regulatory relationships. Thus, we sought to infer the
‘‘signs’’ (activating or inhibiting) of regulatory relationships
from data.
To do so, we first evaluated how phosphorylation at a specific
site is likely to affect a given kinase’s activity, according to anno-
tations from the PhosphoSitePlus database (Hornbeck et al.,
2015). We found particular discrimination for sites within
phosphorylation hotspots of the protein-kinase domain(Strumillo et al., 2019): sites within hotspots
tend overwhelmingly to be activating (i.e.,
within the kinase activation loop) (one-sided
Wilcoxon rank sum test, W = 1.5 3 103, p <
1 3 106 ) (Figure 3A, first panel). When
considering the sites’ positions within the
domain, we found that most inhibitory sites
are N-terminal (one-sided Wilcoxon rank
sum test, W = 1.5 3 103, p = 0.045) (Fig-
ure 3A, second panel). On the other hand,
inhibitory sites tended to be more C-terminal
in the overall protein, although the difference
was not significant, (one-sided Wilcoxon
rank sum test, W = 7.5 3 103, p = 0.38) (Fig-
ure 3A, third panel). Lastly, we also observed
that activating sites tend to be in more struc-
tured regions of the protein and inhibitory
sites are more likely to be disordered,although 50% of all inhibitory sites still were predicted to be in
structured regions (one-sided Wilcoxon rank sum test, W =
5.3 3 103, p = 1.3 3 104) (Figure 3A, fourth panel).
We then trained a predictor of phosphosite regulatory sign
using these features (Table S1) via the Bayesian additive
regression trees (BART) method. Cross-validation of the
model showed consistently good performance, with a
maximum mean Matthew’s correlation coefficient of 0.42 at
a cutoff of 0.58 (posterior probabilities lower than the cutoff
are declared to reflect inhibitory functionality), indicating
overall good sign-classification performance (Figure 3B). Ad-
justing these posterior probabilities by the highest-performing
cutoff provided us with a sign score for all phosphosites in
our dataset, with negative scores indicating a prediction ofCell Systems 10, 384–396, May 20, 2020 387
Figure 3. Evidence of Regulatory Sign (Activating versus Inhibiting) Can Be Uncovered in a Data-Driven Manner
(A) The regulatory sign of a single phosphosite, as annotated in PhosphoSitePlus, can be discriminated by using structural information: whether the site is in a
phosphorylation hotspot, where the site is within the protein-kinase domain (N, N-terminal; C, C-terminal), the relative position of the site within the protein (N,
N-terminal; C, C-terminal), and whether the site is in a disordered region.
(B) Matthews correlation coefficients for different posterior probability cutoffs for the predictor of phosphosite regulatory sign. The cutoff (above which a site or
relationship would be declared to be ‘‘activating’’) that maximizes the coefficient discriminates best between inhibitory and activating sites or relationships. Error
bars represent 95% confidence intervals.
(C) Modifying the phospho-coregulation score to account for predicted phosphosite sign and correlation sign can produce protein-level predictions of regulatory
sign. Here, CDK1 is shown to have an activating relationship with MAPK6 via S189 and an inhibitory relationship with MAP2K2 via S295. Gray cells indicate
missing or removed values.
(D) The signed variants of the coregulation score, functional score, and DCG, all discriminate between inhibitory and activating kinase-kinase regulatory re-
lationships annotated in OmniPath.
(E) Accounting for predicted phosphosite sign can assess the propensity of a kinase to phosphorylate activating or inhibiting sites: BRAF’s PSSMscores highly for
activating sites on MAP2K1, while MAPK3 scores highly for inhibitory sites.
(F) A modified DCG for signed functional scores correctly assigns BRAF as an activator of MAP2K1 andMAPK3 as an inhibitor. Because there are more inhibitory
sites on MAP2K1, a full DCG would be negative in most cases (dotted lines). Instead, we take the most extreme value visited by the sum (solid lines).
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(Table S2).
Kinase Regulatory Sign Can Be Inferred from
Phosphosite Sign and Interaction Evidence
With phosphosite sign predictions in hand, we aimed to predict
the signs of kinase-kinase regulatory interactions. Returning to
the coregulation of functional phosphosites, we tested the
consistency of the observed phosphoproteomic correlation
with the sign of the phosphorylating kinase’s regulatory site. If
phosphorylation of an inhibitory site on a kinase is anticorre-
lated with that of an activating site on a putative substrate,
then the evidence would suggest that the kinase positively
regulates the substrate’s activity. On the other hand, no direct
regulation scenario would explain a positive correlation be-
tween these sites.
For example, cyclin-dependent kinase 1 (CDK1) shows strong
evidence of negative coregulation with dual specificity mitogen-
activated protein kinase kinase 2 (MAP2K2) at its site S295, re-
flecting its role in inhibiting MAP kinase kinases (Rossomando
et al., 1994) (Figure 3C). CDK1 also activates MAPK6 (Tanguay
et al., 2010) and, indeed, we find a strong positive correlation be-
tween two activating sites (CDK1 T161 and MAPK6 S189) on
these kinases (Figure 3C). Overall, we found that the signed
coregulation score was able to discriminate between activating
and inhibitory kinase regulatory relationships, as annotated in
OmniPath, in both phosphoproteomic datasets with activating
relationship tending to have more positive coregulation score
even though, in the case of the Wilkes study, the difference
was not significant (one-sided Wilcoxon rank sum test, W =
6.8 3 102, p = 0.079 [Wilkes et al., 2015] and W = 1.1 3 104,
p = 0.0067 [Mertins et al., 2016]) (Figure 3D, first and second
panels).
We also adapted our DCG methodology after applying our
sign predictions to the site functional scores. Thus, we now
asked whether a kinase’s PSSM tends to find relevant activating
sites or inhibitory sites. For example, dual specificity MAP2K1 is
activated by serine/threonine-protein kinase B-raf (BRAF) (Alessi
et al., 1994; Macdonald et al., 1993; Papin et al., 1995) and is in-
hibited in negative feedback by its downstream substrate,
MAPK3 (Eblen et al., 2004). We found that, indeed, B-raf has
specificity toward MAP2K1’s activating sites while MAPK3 is
specific toward the inhibitory sites (Figure 3E). We then calcu-
lated a DCG on the signed functional scores, taking the most
extreme value visited by the sum (Figure 3F). This method pro-
vides a positive value for BRAF and a negative value for
MAPK3, as expected. Overall, both the signed functional score
and the signed DCG score could discriminate well between
activating and inhibitory relationships (one-sided Wilcoxon
rank sum test, W = 2.1 3 104, p < 1 3 106 (signed DCG) and
W= 2.33 104, p < 13 106 [signed functional score]) (Figure 3D,
third and fourth panels). However, predictions for inhibitory
relationships overall were less reliable.
A Supervised Learning Model Predicts a Global Network
of Kinase Regulatory Relationships from Diverse
Features
We combined the above evidence into two predictors via ma-
chine learning. The edge predictor predicts whether a kinase-ki-nase regulatory relationship exists. The sign predictor predicts
whether a given relationship induces or inhibits the substrate’s
kinase activity.
For training and validating the edge predictor, we retrieved
from the OmniPath meta-database (T€urei et al., 2016) a list of
annotated relationships with at least two source databases
supporting them, comprising 825 interactions in all. Because it
is more difficult to prove the absence of a regulatory relationship,
there is a lack of annotations for genuinely false relationships.
We assumed that, in the space of all possible kinase-kinase
interactions, regulatory relationships are rare. Therefore, a
randomly selected pair of kinases is unlikely to show any regula-
tory relationship. We thus assessed the features described
above for their predictive power on a validation set consisting
of the annotated positive cases and random ‘‘negative’’ subsets
of the remaining space of putative interactions.
Overall, each of the edge predictor features (Table S3) ex-
hibited limited but measurable predictive power. We visualized
this by the receiver operating characteristic (ROC) curve,
comparing true-positive and false-positive rates as the score
cutoff for declaring a regulatory relationship is lowered, and by
similarly assessing precision and recall across cutoffs (Fig-
ure 4A). Maximum PSSM score performed the best, with a
mean area under the ROC curve (AUC) of 0.742 (s= 0:007;
n= 100) (Figure S1A). The remaining features had mean AUC
values of less than 0.7. We also noted that the precision decayed
rapidly with lower cutoffs.
We then combined these features into the edge predictor
with the BART method (Chipman et al., 2010) (Table S4). We first
performed 3-fold cross-validation on the model 20 times using
different random iterations of the training set (Figure 4A). The
resulting models had a mean AUC of 0.884 (s= 0:009; n= 60),
representing a significant improvement over the individual
features (Figure S1A).
We applied the same BART method to the regulatory sign
features (Table S5) to produce the sign predictor (Table S4).
We trained the model using regulatory signs annotated in Omni-
Path and evaluated it through cross-validation. Overall, perfor-
mance was similar to the underlying site-level predictor
described above, with a mean maximum Matthews correlation
coefficient of 0.42; however, confidence intervals over the
cross-validation were narrower for kinase-level predictions
than they were for site-level predictions (Figure 4B). The
maximum correlation occurred at a cutoff of 0.484 (i.e., the prob-
ability above which we would declare regulation to activate the
substrate).
We next considered whether known, annotated relationships
tend to rank highly among our edge predictions for each kinase.
After building a new model for each kinase without using any
of its annotated relationships in the training set, we found that
50% of kinases had a known regulatory relationship within the
top 10 of our predictions (Figure 4C). The top ranks were signif-
icantly better than expected, based on random, per-kinase
permutations of the scores (one-sided Wilcoxon rank sum test,
regulator: W = 5;818:5; p<13 106; substrate: W = 7;385:5;
p<13 106).
To further evaluate our model, we looked at how well it pre-
dicted interactions that were not included in the positive set
due to being supported by only one source in OmniPathCell Systems 10, 384–396, May 20, 2020 389
Figure 4. Combining Data-Driven Predictors of Kinase-Kinase Regulatory Relationships
(A) ROC and precision-recall curves of each feature and the final edge predictor. See also Figure S1A.
(B) Matthews correlation coefficients for different posterior probability cutoffs for the sign predictor. Error bars represent 95% confidence intervals.
(C) Annotated regulatory relationships for each kinase tend to rank highly among the predictions, when considering the kinase as either a regulator or a substrate.
Lines indicate quartiles. 50% of kinases had a known regulatory relationship in the top ten predictions, which is significantly better than random expectation. See
also Figure S2B.
(D) Previously annotated relationships supported by only one source in OmniPath score similarly to those supported by two or more sources (used in our training
set), further validating our predictions.
(E) Clusters identified on the regulatory sub-network at a posterior probability cutoff of 0.5 are significantly enriched in annotations for unique sets of pathways.
See also Figures S1B and S1C.
(F) The predicted network expands upon the annotated network, especially for understudied protein kinases. See also Figure S2A.
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scores than unannotated regulatory interactions; however, they
were generally lower than the high-confidence set (one-
sided Wilcoxon rank sum test versus unannotated: W = 63
107; p<13 106, versus high-confidence set: W = 87;073; p<
13 106; Figure 4D).
We also noted several high-probability predictions that, while
not being annotated in OmniPath, have direct or plausible sup-
port in the literature. For example, we predict receptor tyrosine
protein kinase erbB-2 (ERBB2/HER2) to activate ephrin type-A
receptor 2 (EPHA2) (edge probability 0.94 and sign probability
0.79). These two oncogenic kinases form a complex, and in a390 Cell Systems 10, 384–396, May 20, 2020mouse model of breast cancer, they appear to cooperate to pro-
mote tumor progression (Brantley-Sieders et al., 2008); however,
no direct regulatory relationship has yet been described.We also
predict that the closely related tyrosine protein kinases Fer (FER)
and Fes/Fps (FES) activate HGF receptor (MET) with equal prob-
abilities (edge probabilities 0.92 and sign probabilities 0.80). In
fact, activation of MET by FER has previously been reported
(Fan et al., 2016); however, this relationship is not annotated in
OmniPath and thus was not present in our training and validation
set. As a final example, we predict tyrosine protein kinase ABL1
to activate focal adhesion kinase 1 (PTK2/FAK1) (edge probabil-
ity 0.92, sign probability 0.81). While, to our knowledge, no such
ll
OPEN ACCESSArticleregulatory relationship has been described previously, FAK1
plays an important role in acute lymphoblastic leukemia charac-
terized by constitutively active ABL1, and its phosphorylation
was speculated to be ‘‘likely augmented by the direct action of
activated ABL1 itself’’ (Churchman et al., 2016).
We next assessed the topology of regulatory relationships us-
ing a sub-network of high-confidence predictions (probability
greater than 0.5), consisting of 340 kinases and 4,339 regulatory
relationships (representing less than 2% of all possible relation-
ships). We first applied a cluster-detection algorithm to an undi-
rected variant of this network (retaining the higher probability
relationship when two kinases were predicted to regulate each
other, producing 3,716 undirected edges). Four clusters were
detected (103, 45, 105, and 87 kinases, respectively; Table
S6). This division of the network had amodularity of 0.325, which
was significantly higher than expected given the modularity of
randomized networks with the same degree distribution (m=
0:197; s= 0:00339;p<0:001; Figure S1B). To determine if these
clusters reflected known biological associations, we tested
each one for enrichment in pathway annotations from Reactome
(Fabregat et al., 2017). Each cluster was enriched in annotations
for at least one distinct Reactome pathway, indicating that the
network successfully identified clusters of physiologically related
kinases (Figure 4E; Table S7). We also assessed how related the
pathways associated with each cluster were, using the average
number of reactions between the proteins of two pathways as a
proxy for relatedness. We found that the pathways associated
with the same cluster were more closely related to each other
than to those associated with other clusters (p<13 106, W =
5:83 105, Wilcoxon rank sum test; Figure S1C).
Because we set out to overcome the shortcomings inherent to
literature-derived signaling pathway annotations, we checked
for relationships between kinase connectivity on the high-confi-
dence network and kinase publication counts (Figure 4F; kinase
publication counts were retrieved from, Invergo and Beltrao,
2018). Interactions between kinases in the top three publica-
tion-count deciles (more than 95 publications) accounted for
only 31% of the network. Conversely, 589 regulatory relation-
ships were predicted between pairs of kinases in the bottom
50% of publication counts (fewer than 40 publications each).
Overall, only 7% of the relationships in the high-confidence
network are annotated in databases. This portion increases as
a higher probability threshold is applied to the network (Table
S8). Although the number of previously annotated interactions
is dwarfed by novel predictions, a significant proportion of this
can be accounted for by the relative sparsity of annotated rela-
tionships for understudied kinases. Restricting the network to
highly studied kinases largely resolves this (Figure S2A). Howev-
er, this can also be explained in part by a persistence of the influ-
ence of better annotation for well-studied kinases in our predic-
tions, as can be seen in a significant correlation between
publication count and top prediction-rank of known relationships
(Figure S2B; Spearman’s rank correlation, as regulator: r= 
0:34;p<13 106; as substrate: r=  0:29;p<1 3 106).
The Trained Model Can Reconstruct Known Signaling
Pathways
We next investigated whether our data-driven, signed kinase-ki-
nase regulatory predictions were able to reconstruct knownpathways. For each kinase that we include, we generated a
new model for which all regulatory relationships including the ki-
nase were left out of the training set. These kinase-specific
models were then used to predict the kinase’s regulatory sub-
strates and the signs of the interactions. To these we applied
an edge probability cutoff of 0.5 and a sign cutoff of 0.5. We
started by choosing well-studied kinases that are functionally
related to AKT1 (Figure 5A). Between these kinases, we success-
fully recovered all but one annotated relationship, the regulation
of ribosomal protein S6 kinase beta-1 (RPS6KB1) by AKT1 and
PDPK1. Six predicted relationships are not present in database
annotations. Sign predictions generally fail on a per-substrate
basis. For example, we predict all regulations of serine/threo-
nine-protein kinase mTOR (MTOR) to be inhibitory, while those
that have been annotated are activating. Our predictions also
perform well when considering MAPK signaling, recovering all
but three previously annotated edge, and with two erroneous
predictions of an annotated sign (Figure 5B).
If we begin to include other paralogs of these kinases, which
tend to be less well studied, we quickly accumulate predictions
for previously undescribed relationships. For example, we pre-
dict many modes of inter-regulation between S6 kinases and
glycogen synthase kinases. On the other hand, we fail to predict
several regulatory relationships involving RAC protein kinases
AKT2 and AKT3 (Figure 5C). Expanding the MAPK signaling
network is more successful, with the core signaling events being
recovered between RAFs, MAP2Ks, and MAPKs, including cor-
rect sign prediction, while also filling in the network of interac-
tions for the less well-studied A-Raf (ARAF) and MAP2K3 (Fig-
ure 5D). Both of these examples demonstrate that the
predicted networks quickly become difficult to assess visually
when more than a few kinases are included, particularly those
with fewer annotations, because of the numbers of unvalidated
predictions. However, extrapolating from the overall perfor-
mance and the success on smaller networks, our results suggest
that this complexity is inherent to kinase signaling networks.
Independent Experimental Data Support Predicted
Regulatory Relationships
We next investigated whether our predictions are reflected in ki-
nase-target relationships identified in large-scale phosphopro-
teomics experiments that were not used for training. First, we
employed two recently published datasets. In one, Sugiyama
et al. (Sugiyama et al., 2019) have identified in vitro substrate
phosphosites for 354 human kinases. In the second study, in vivo
phosphosites that are directly or indirectly ‘‘downstream’’ of 103
kinases were determined by phosphoproteomic experiments af-
ter chemical inhibition of kinase activity (Hijazi et al., 2020).
Together, these two datasets define kinase-substrate phospho-
sites relationships, from which we selected kinase-kinase phos-
phorylation relationships that we reasoned should be enriched in
regulatory interactions. We note however that these studies
identify whether a kinase could be responsible (directly or indi-
rectly) for the phosphorylation of another but not necessarily
whether such phosphorylation is regulatory.
We looked at probability scores assigned to relationships
that were corroborated by these experiments. Relationships
included in our validation set were discarded. In both cases,
we observed that the probability score derived from our model
was significantly higher for these experimentally identifiedCell Systems 10, 384–396, May 20, 2020 391
Figure 5. Our Data-Driven Predictor Reconstructs Known Signaling Pathways ‘‘from Scratch’’
Each kinase’s outgoing edges and signs were predicted from models trained after leaving the kinase out from the training set. A probability cutoff of 0.5 and
‘‘activating’’ sign cutoff of 0.5 were used. Black edges are relationships annotated in OmniPath that were correctly recovered. Red edges are annotated re-
lationships that were not predicted. Gray edges are unvalidated predictions. Arrowheads indicate the predicted regulatory sign: arrows indicate activation and
bars indicate inhibition. Black arrows are correctly predicted, red arrows are incorrectly predicted, and gray arrows are unvalidated. Node colors indicate the
number of publications associated with the kinase. Kinases with fewer associated publications (‘‘cool’’ blue/green colors) tend to have more unvalidated edges.
(A) A reconstruction of AKT1 signaling using only well-studied kinases largely recovers the known information flow of the pathway.
(B) Similar performance is seen in reconstructing MAP kinase signaling.
(C) Including lesser-studied kinases in the AKT signaling analysis greatly increases the number of unannotated or missed relationships while also predicting
complex modes of regulatory feedback.
(D) Expanding the MAP kinase signaling pathway to include more paralogs captures a highly interconnected core of previously annotated relationships while
adding numerous unvalidated relationships between lesser-studied kinases.
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median probability of 0.075 (W = 2.63 3 108, p < 1 3 106);
in vivo: median probability of 0.12 (W = 1.57 3 108, p < 1 3
106); background: median probability of 0.030) (Figure 6A).
In addition, a subset of these experimental target sites was
found at positions with a higher regulatory potential based
on the phosphosite functional score (Ochoa et al., 2020).
When filtering the in vitro and in vivo kinase-kinase interac-
tions by the phosphosite functional score cutoff of 0.5
we observe an increase in the median probability from our
model (Figure 6A), in particular for the in vivo kinase-kinase
target set (Figure 6A, ‘‘in vivo fnc’’). Both the in vitro set
(W = 1.03 3 108, p < 1 3 106 ) and in vivo set (W = 8.81 3
107, p < 1 3 106) filtered by the phosphosite functional score
have a significantly higher edge probability than the back-
ground set. Furthermore, predicted network edges corrobo-
rated by either study had a higher probability of being
included in our validation set with Fisher’s exact test (OR =
3.98 and p = 1.6 3 104 for the in vivo study and OR = 4.51
and p < 1 3 106 for the in vitro study). We provide in Table
S9 the list of kinase-kinase regulatory relationships that have
a high predicted score from our model having also in vivo or
in vitro supporting evidence. This includes 3 cases of unanno-
tated kinase-kinase relationships with support from both the
in vitro and in vivo experiments.392 Cell Systems 10, 384–396, May 20, 2020Finally, as an application of our predictions, we tested whether
phosphorylation perturbation data could be used to discover
novel pathways within the inferred network. To this end, we
measured changes in phosphorylation after treatment of human
cells (Kasumi-1 cell line) with MEK and PI3K inhibitors via phos-
phoproteomics (Table S10). A total of 9,183 phosphopeptides
were quantified for MEKi and PI3Ki and control condition, with
66 and 112 phosphosites identified as significantly downregu-
lated after inhibition. Of measured phosphosites, 650 had a
known upstream kinase included in our high-probability network
leading to 1,019 kinase-substrate interactions being added to
the network. After omitting sites known to be direct substrates
of MEK and PI3K as well as sites without any known kinase, 6
and 11 downregulated phosphosites were considered for subse-
quent analysis. We then asked if the inhibition of MEK (MAP2K1
and MAP2K2) and PI3K kinases could be linked to the downre-
gulated phosphosites via connections predicted by our model.
A probability cutoff of 0.5 was used to retain a network of highly
probable edges and owing to the fact that PI3K is a lipid kinase,
PI3K was linked to the network via its known substrate kinases.
The regulated phosphosites were added to the predicted kinase
network based on prior knowledge, and the distances between
the inhibited kinases and the downregulated phosphosites
were calculated as the sum of weights across the shortest
weighted path on the predicted network. We found that
A C
B
Figure 6. Network Validation with Independent Experimental Data
(A) Edges corroborated by either in vitro or in vivo datasets had higher probability, 0.075 (n = 1,596) and 0.12 (n = 856), respectively, compared with otherwise
unsupported edges, 0.030 (n = 251,159). Edges filtered by functional score had yet higher probability assigned to them; 0.083 (n = 602) and 0.15 (n = 456).
(B) Downregulated phosphosites tended to be closer in terms of weighted shortest path to perturbed kinases.
(C) Connecting downregulated phosphosites to perturbed kinases by traversing through the shortest weighted path in the network yielded two predicted in-
teractions corroborated by the in vitro data (SRC and CDK1/2) and one predicted interaction supported by both the in vitro and in vivo datasets (MAPK1 and
PRFF4B). Known edges were derived from the OmniPath validation set apart from the edge between PI3K and SRC, which was derived from KEGG.
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nases than all other quantified phosphosites (W = 1.4 3 104,
p = 0.0028) (Figure 6B). We then selected paths connecting the
inhibited kinases with downregulated phosphosites via edges
that had support from at least one of the kinase-target experi-
ments described above (Figure 6C). In this way, we identified pu-
tative kinase regulatory interactions that have a high-probability
score (>0.5), are supported by in vitro or in vivo kinase-target ex-
periments, and help to explain downregulation of phosphosites
from our kinase inhibition experiments. This includes 2 related
relationships (Figure 6C) between SRC and two CDKs (CDK1
and CDK2) and the predicted regulation of PRPF4B by
MAPK1. The latter was supported by both the in vitro and in vivo
studies.
DISCUSSION
The task of experimentally testing all possible kinase-kinase re-
lationships in order to produce a complete regulatory network
is daunting. We have thus taken a data-driven supervised
machine learning-based approach to predict these regulatory re-
lationships. Although we do not suggest that these predictions
can replace established methods for confirming regulatory rela-
tionships, they can nevertheless be used to reduce the vast
space of possible relationships under consideration in order to
form credible hypotheses and to prioritize experiments, particu-
larly for understudied kinases.
Previous efforts to produce kinome-scale inferences of regula-
tory relationships have depended on scaffolding data-drivenpredictions to existing protein networks. For example, Rudolph
et al. (2016) derived signaling pathways through a network
diffusion technique with phosphoproteomic data on a litera-
ture-derived protein-protein interaction network. However,
such analyses are strongly impacted by the incompleteness of
the existing networks and the overrepresentation of well-studied
kinases therein (Gillis et al., 2014; Invergo and Beltrao, 2018;
Rolland et al., 2014). To our knowledge, there has only been
one other attempt to predict kinase regulatory sign (Hernandez
et al., 2010). The authors inferred signs from quantitative phos-
phoproteomic data on a literature-derived kinase network, in
which the method in part depended upon the connectivity of
the kinases on this network. However, missing or erroneous an-
notated relationships could have major impacts on the results.
Our supervised machine learning approach can make predic-
tions for kinases with no previously known information, in this
way improving the coverage in our predicted network. We only
retain a literature influence, which might affect the generality of
our model, from using annotated substrates in the construction
of our kinase specificity models and from the construction of
the training set. The former can be resolvedwith high-throughput
methods to measure kinase specificity profiles (see, e.g., Ima-
mura et al., 2014, Sugiyama et al., 2019). The latter, which could
omit highly specialized modes of regulation, can be improved as
more relationships are experimentally validated.
Many factors can affect the nature of a kinase-kinase regula-
tory relationship and each such relationship will be unique,
owing to the particular properties of the kinases involved.
Thus, making generalized predictions that apply to all of themCell Systems 10, 384–396, May 20, 2020 393
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mental, such as regulation by phosphorylation, and identifica-
tion of how much each of such features contribute to the spec-
ificity in kinase-substrate interaction will be key in predicting the
regulatory roles of phosphorylation sites. To this end, the per-
formance of the predictions via identifying patterns of phos-
phorylation will improve with more data. Given the importance
of PSSMs in our results, there is a clear need for producing
robust PSSMs for every kinase in order to prune indirect regu-
latory effects. As for correlative methods on phosphoproteomic
data, many conditions are needed to confidently discriminate
the phosphoregulation of over 500 kinases. Importantly, large-
scale phosphoproteomics experiments are needed across a
more diverse array of tissues or cell lines to properly capture
the activities of more tissue-specific kinases. Because we
only used data from experiments using the breast cancer cell
line MCF7, many kinases were not represented in the phospho-
proteomic data. Furthermore, the use of data derived from can-
cer cell lines might introduce errors in the resulting network
since cancer initiation and progression disrupt intracellular
signaling (Sever and Brugge, 2015).
We assumed in the construction of our predictor that the true
network is sparse, and indeed we assign to 75% of all possible
relationships posterior probabilities of less than 0.09, far below
any probability cutoff that we considered. Nevertheless, even
at stringent cutoffs, isolating a sub-network of more than a few
kinases produces a denser topology of regulatory relationships
than is typically considered for kinase signaling. It is possible
that this is an artifact of not considering cellular context (e.g.,
protein expression or cellular localization). There is also an un-
avoidable accumulation of false-positives as more predictions
are considered. Despite these caveats, our results suggest
that the kinase regulatory network is richer in feedback and
cross-module regulation than expected based on the current
view of kinase pathways. Further developments in experimental
approaches for hypothesis-free kinase regulatory network
reconstruction are needed to confirm the predicted modularity
and density of regulatory relationships in kinase signaling
networks.Key Changes Prompted by Reviewer Comments
In response to reviewer comments, we have added validation
analyses on the external in vitro (Sugiyamaet al., 2019) and in vivo
(Hijazi et al., 2020) datasets, as well as validation on a newly
generated phosphoproteomic dataset. This resulted in the addi-
tion of Figure 6. We also added statistical tests to support the
assessment of each feature’s discriminatory power. We updated
the methodology used to generate Figure 5 in order to assure
that each kinase was removed from the training set before pre-
dicting its regulatory relationships. Finally, we added Table S8
to better illustrate the network at different score cutoffs. For
context, the complete transparent peer review record is included
within the Supplemental Information.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Kasumi-1 cells (Male) were routinely cultured using RPMI (10% FBS, 1%penicillin/streptomycin) at 37C, in a humidified atmosphere
containing 5%CO2. Each kinase inhibitor was diluted to 1000 times the desired concentration for treatment using DMSO. Cells were




Wedefined the human kinome as the list of 504 human proteins identified as protein kinases in the UniProt/Swiss-Prot Protein Knowl-
edgebase, pkinfam (accessed 8 November 2017 at https://www.uniprot.org/docs/pkinfam). Quantitative phosphoproteomic data
were retrieved from two publications. The first included phosphosite quantifications of 213 phosphosites for 100 kinases across
22 kinase-inhibitory conditions in MCF7 cells (Wilkes et al., 2015). The second quantified 1537 phosphosites on 193 kinases across
83 breast tumor samples (Mertins et al., 2016). Tissue RNA expression data for protein kinases were retrieved from the GTEx project
(GTEx Consortium, 2013) as provided by Expression Atlas (E-MTAB-5214, timestamp 26April 2018) (Papatheodorou et al., 2018).We
furthermore retrieved tissue RNA expression data from the Human Protein Atlas project (accessed from www.proteinatlas.org 1
December 2017) (Uhlén et al., 2015). Lists of human phosphosites, kinase substrates, and kinase regulatory sites were retrieved
from the PhosphoSitePlus database (accessedMay 1, 2018) (Hornbeck et al., 2015). Amino acid frequencies in the human proteome
were derived from the UniProt proteome database (UniProt Consortium, 2018). In vitro kinase substrate list was retrieved from a pub-
lication by Sugiyama and colleagues (Sugiyama et al., 2019). In vivo kinase substrate list was retrieved from apublication byHijazi and
colleagues (Hijazi et al., 2020).
Protein Kinase Specificity Models
Constructing Kinase Specificity Models
We estimated kinase specificity through the construction of position-specific scoring matrices (PSSMs) from the amino acid se-
quences around known substrate sites (+/7 residues), omitting autophosphorylation sites. We required at least 10 known sub-
strates in order to build a PSSM for a given kinase, resulting in PSSMs for 140 protein kinases. In order to reduce the influence of
redundant sequences on the construction of the matrices, we employed a position-based sequence-weighting method (Henikoff
and Henikoff, 1994).
Given a set of nR10 substrate amino-acid sequences, S= fS1;S2;.;Si;.;Sn1;Sng, where Si = fSi1;Si2;.;Si14;Si15g and Sij rep-
resents the amino acid at position j of sequence i, we give a weight to each of amino acid a at position j as follows:
wða; jÞ = 1
cj
Pn
i = 1ðSij = aÞ
where cj is the number of unique amino acids found in position j among the substrates in S. Next, a weight is calculated for each





Finally, each sequence weight was normalized by the sum of all sequence weights:
cWðSiÞ = WðSiÞPn
k = 1WðSkÞ
A 20 315 PSSM can then be constructed as follows. First, we construct matrix r, such that entry raj contains the weighted count of




VðSij; aÞVðSij; aÞ =
 cWðSiÞ; if Sij = a
0; otherwisee2 Cell Systems 10, 384–396.e1–e9, May 20, 2020
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unlikely to accurately estimate low-probability occurrences. To overcome this, we added pseudocounts based on proteome-wide
amino-acid frequencies in a position-specificmanner (Henikoff and Henikoff, 1996). For each column j in the PSSM, we select a num-
ber of pseudocounts, Bj, to add:
Bj = m3 cj
wherem is a tune-able parameter and cj is defined as above. Thus, empirically constrained positions (e.g. the +1 position for proline-
directed kinases) will receive fewer pseudocounts, and thus lower baseline probabilities of observing other residues, than highly var-
iable positions. We found that our results were not strongly dependent onm, so we fixed it at 1. A 20 315 matrix of pseudocounts, b,
was then calculated as follows:
baj = Bj 3 fa
where fa is the occurrence frequency of amino acid a in the proteome. This allows us to derive an empirical matrix of probabilities, p, of
observing amino acid m at position j:




The final PSSM was arrived at by calculating the log2 fold-change of paj versus the proteome-wide amino acid frequencies:
PWMaj = bpða; jÞ= log2pða; jÞfa

Assigning PSSMs to Protein Kinases
In order to increase our coverage of specificity profiles to include protein kinases with few or no known substrates, we assigned to
them either composite, family-wise PSSMs or PSSMs of protein kinases with similar specificity determining residues (SDRs) (Bradley
et al., 2018). For each protein kinase family, we constructed a family-wise PSSM as described above using known substrates of all
kinases in the family, as defined by the KinBase resource (Manning et al., 2002) (http://kinase.com/web/current/kinbase/). This fam-
ily-wise PSSM was then assigned to any member of the family for which we could not construct a unique PSSM. PSSMs were as-
signed to 209 protein kinases in this manner.
Finally, for the remaining protein kinases for which no family-wise PSSM was available, we attempted to assign a PSSM based on
SDR similarity. Towards this end, 10 kinase domain positions were selected, representing residues known to covary with kinase
specificity and that are proximal (<4Å distance) to the kinase substrate at the active site (Bradley et al., 2018). For a given pair of ki-
nases, sequence similarity across the 10 SDRs was calculated by summing BLOSUM62 substitution scores for each position. An
‘SDR similarity’ score was then calculated by dividing this sum by the maximum possible score across the 10 SDRs, such that iden-
tical kinases would yield a similarity score of 1.0.
As represented in Figure 2A, the relationship between SDR similarity and PSSM distance was explored systematically to decide
upon an SDR similarity threshold to use for PSSM assignment. For this purpose, SDR similarity scores and PSSM distances were
calculated for all possible pairwise comparisons of kinases with known specificity. Here, similarity between PSSMs was quantified
using the Frobenius distance, which represents the sum of squared element-wise distances between matrix values, followed by tak-
ing the square-root (Ellis and Kobe, 2011). For reference, pairwise Frobenius distances were also calculated for PSSMs of the same
kinase by subsampling known target sites of a given kinase, using a sample size of 25 targets sites (corresponding to the median
number of target sites used for PSSM construction). The distribution of all possible pairwise distances among these ‘duplicate’
PSSMs had a median of 1.00 and a 97.5th percentile of 1.10 (Figure 2A, red line). We interpret PSSM distances below the 97.5th
percentile to represent kinases with the same active site specificity. An SDR similarity threshold of 0.8 was therefore selected as
more than half of kinase pairs above this value have PSSM distances below the 1.10 threshold. For PSSM assignment, targets
from the most similar kinase(s) in the human kinome were selected, provided the SDR similarity score was above 0.8. We assigned
PSSMs to a further 14 kinases through this method. For all PSSM comparisons, the phospho-acceptor column (P0: S/T/Y) was not
used when calculating the Frobenius distance.
The predictive performance of family-based and SDR-based PSSM predictions was compared in Figure 2B. For every kinase of
known specificity, a PSSM was assigned using the family-based and SDR-based approaches described above, and then the Fro-
benius distance between empirical and predicted PSSMs was calculated for both prediction methods.
Scoring Phosphosites with PSSMs
For each directed protein kinase-kinase relationship, we scored each known phosphosite on the substrate kinase using the upstream
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sbs =  smin
smax  smin
Phosphosite Functional Scores
Predictions of functional relevance of phosphosites were retrieved from (Ochoa et al., 2020). The predictions were made on a variety
of phosphosite structural, evolutionary and biochemical features. As the predictions were originally made on a strictly defined set of
phosphosites derived from a reanalysis of a set of high-throughput phosphoproteomics experiments, not all of the phosphosites
available in the PhosphoSitePlus database were represented. We log10-transformed the raw scores and normalized them against
the minimum and maximum values to arrive at functional scores valued between 0.0 and 1.0, with larger scores reflecting a greater
expectation of a functional impact of phosphorylation at that site.
Linking PSSMs to Phosphosite Functional Scores
We assessed a kinase’s potential to phosphorylate a putative substrate at sites of likely functional relevance by linking the kinase’s
PSSM to the substrate’s phosphosite functional scores via a Discounted Cumulative Gain calculation (DCG). In effect, we treat the
PSSM as a ‘‘search function’’ and we employ the functional scores as relevance scores to determine how well a PSSM ‘‘finds’’ func-
tional sites. For each substrate phosphosite with a functional score available, we calculate the PSSM score bs as above. Next, the n
sites are ranked by bs in descending order, producing an associated ordering of functional scores F = fF1;F2;.;Fi;.;Fn1;Fng. The






Sites with higher PSSM scores, and thus lower rank i, contribute larger fractions of their functional scores to the sum. The DCGwill
be highest, then, if sites with high functional scores tend to have high PSSM scores.
In order to make DCG scores comparable between different kinase-substrate pairs, we normalized each score by the minimum
and maximum possible DCG scores for the substrate. The minimum DCG for a substrate can be found by sorting the sites in
ascending order of their functional scores; likewise, the maximum can be found by sorting the sites in descending order of their func-




Coexpression and Tissue Specificity
Coexpression of protein kinases across tissues in the GTEx and Protein Atlas RNA expression datasets was calculated via Spear-
man’s correlation after setting missing values to 0.0.
The tissue specificity of each kinase was calculated by assessing the skewness of its distribution of Protein Atlas expression values












i = 1ðxi  xÞ2
q 3
where x is the kinase’s set of expression values across all tissues, x is the sample mean expression value, s is the sample standard
deviation, and m3is the third central moment of the distribution. Skewness was calculated using the ‘‘e1071’’ package for R
(https://CRAN.R-project.org/package=e1071).
Phospho-Coregulation
We assessed coregulation of a pair of protein kinases bymeasuring the correlation between phosphorylation of their regulatory phos-
phosites across conditions (Wilkes et al., 2015) or tissue samples (Mertins et al., 2016) of phosphoproteomic experiments. Both
experiments consisted of a table of log2fold-changes for each quantified phosphosite across the conditions or samples, measuringe4 Cell Systems 10, 384–396.e1–e9, May 20, 2020
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data for each experiment was quantile normalized by condition or sample (Bolstad et al., 2003).
Within an experiment, for each pair of phosphosites on two protein kinases, we calculated the correlation between fold-changes of
the sites across all conditions or samples for which a quantification was available, where at least five such conditions or samples
existed. We first removed any conditions in which one of the kinases was under chemical inhibition. The correlation was calculated
using Spearman’s rho and a p-value estimated for the correlation via the asymptotic t approximation. p-values were then 
log10-transformed; in the case that the estimated p was 0, we set the final value to 6. This value was then scaled by the functional
scores of both sites such that only two sites with high functional scores and a high phosphorylation correlation would have a high final
coregulation score. We then took the maximum such score across all site pairs as the final coregulation score for the kinase pair.
Finally, the coregulation scores for all kinase pairs were normalized according to the maximum and minimum values of all pairs.
Prediction of Regulatory Relationships
Training and Validation Set
We retrieved a high-confidence set of known, directed kinase-kinase regulatory relationships from OmniPath (T€urei et al., 2016)
(fetched Jan 22, 2018 via the Python API). To ensure the quality of the relationships we only used those that were supported by at
least two sources, providing a ‘‘positive’’ set of 825 relationships. It is more challenging to define a ‘‘negative’’ set of regulatory re-
lationships, given the difficulty in unequivocally demonstrating a lack of regulation under all conditions. However, we assume that
regulatory relationships are rare and that, given a random pair of kinases, there is unlikely to be a regulatory relationship between
them. Working under this assumption, we constructed negative sets by randomly sampling from the space of possible relationships.
To further reflect the presumed sparsity of the true network, we chose to construct a negative set that was 8 times larger than the
positive set, which provided a slight improvement in prediction performance. This value was arbitrarily chosen to balance the dimin-
ishing performance boost from increasing negative set size with the rapidly increasing memory resources required to perform the
training computations.
Feature Validation
Weevaluated the performance of the following features for predicting protein kinase regulatory relationships: maximumPSSM score,
maximum substrate phosphosite functional score, DCG, phosphoproteomic coregulation scores, tissue RNA coexpression, and
regulator and substrate tissue expression specificity. Each feature was evaluated 100 times against a randomly sampled two-thirds
of the positive set and an 8-fold larger randomized negative set.
Model Training and Prediction
In order to build a final predictive model of kinase-kinase regulatory relationships, we employed the Bayesian Additive Regression
Trees (BART) method (Chipman et al., 2010). Briefly, BART is a ‘‘sum-of-trees’’ method, in which a series decision trees are fit to
the data and used to classify data. Each tree consists of binary decision nodes reflecting a decision based on one of the features,
e.g. ‘‘max. PSSM score > 0.75’’ or ‘‘GTEx coexpression < 0.3’’. The terminal nodes of the tree contain values which, once selected,
contribute to the final classification value; in a sum-of-treesmodel, the decision values from each tree are summed to produce a value
upon which this final classification is made. The BART method, in particular, uses a fixed number of trees, on which it places regu-
larizing priors that ensure that each tree is a ‘‘weak learner’’, i.e. each tree contributes a small fraction of the final classification value. It
does this by restricting the tree depth, shrinking terminal leaf nodes to themedian, and adding noise to avoid over-fitting. Trees are fit
to the data through Bayesian approaches to estimating the parameters, such as Markov-Chain Monte Carlo (MCMC) backfitting
(Chipman et al., 2010).
We applied the BARTmodel to our data as implemented in the R package ‘‘bartMachine’’ version 1.2.3 (Kapelner andBleich, 2016).
A notable extension of the original method provided by bartMachine is to incorporate data missingness into predictions (Kapelner
and Bleich, 2015). For example, a missing phosphoproteomic coregulation value might be informative as it would indicate that phos-
phosites on the two kinases were never detected in the same conditions by the mass spectrometer, and thus a decision tree node
asking ‘‘is the coregulation score missing?’’ can contribute to the final classification. We used this feature by enabling the ‘‘use_mis-
sing_data’’ and ‘‘use_missing_data_dummies_as_covars’’ parameters and disabling the ‘‘replace_missing_data_with_x_j_bar’’ and
‘‘impute_missingness_with_x_j_bar_for_lm’’ parameters. These settings in effect disable any imputation ofmissing data and produce
new ‘‘dummy’’ variables that indicate whether a value is missing, which can then be incorporated in the decision trees. Model hyper-
parameters including the number of trees were determined using the built-in 5-fold cross-validation routine provided by the ‘‘bart-
MachineCV’’ function.
In addition to the quantitative features listed in the previous section, we also included the kinase types (serine/threonine versus
tyrosine) for the regulating kinase and the substrate kinase as additional features. We evaluated the BART model on these features
using the full ‘‘positive’’ training set and random ‘‘negative’’ training sets as outlined above. To this end, we performed 20 iterations of
3-fold cross-validation, using a different random ‘‘negative’’ set each iteration. We evaluated the true-positive rate, false-positive
rate, the precision (positive predictive value) and the recall (sensitivity) of the model based on the calculated posterior probabilities
assigned to the validation set. Performance metrics were calculated using the R package ROCR (Sing et al., 2005).
In order to produce our final classifications, we trained 100 different BART models to the training set, each with a different random
instantiation of the ‘‘negative’’ set. Each model was then used to produce a posterior probability of a regulatory relationship for all
kinase-kinase pairs. Finally, we took the mean of the 100 posterior probabilities for each relationship as the final classification score.
For the assessment of rankings of known regulators or substrates (Figure 4C) and for the reconstruction of knownpathways (Figure 5),Cell Systems 10, 384–396.e1–e9, May 20, 2020 e5
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removing all relationships including that kinase, and random instantiations of the ‘‘negative’’ set. The mean posterior probability of
each of that kinase’s relationships from these 3 models was used as the final prediction for the analysis.
Network Clustering and Pathway Enrichment
The resulting networkwas divided into clusters using themethod of Blondel et al. (2008) as implemented by the R package ‘‘igraph’’ in
the function ‘‘cluster_louvain’’ (Csárdi and Nepusz, 2006). This is a heuristic method that identifies clusters by optimizing modularity.
The algorithm can be divided into two steps: first, a cluster is assigned to each node in the network. Next, one node i is iteratively re-
assigned to each of its neighbors’ clusters and the impact on the network’s modularity is assessed. Node i is then re-assigned to the
cluster where its inclusion results in the greatest gain in modularity. This process is repeated until no gain in modularity can be
achieved, that is, a local maximum has been found. In the second step, a new network is constructed from the identified clusters.
Edge weights between the nodes, including self-loops, are computed by summing over the weights of the links that connect nodes
in each cluster. The first step is then reapplied on the resulting network. These two steps are then repeated iteratively to improve the
cluster assignments.
Our aim is to predict regulatory relationships between kinases and as a result our network is directed, that is up to two directed
edges connect each pair of kinases, one for each direction of regulation. As this method only clusters networks with at most one
edge connecting each node pair, we retained the higher-probability edge of the two linking each pair of nodes. Prior to clustering,
we removed regulatory relationships with posterior probabilities less than 0.5 in order to only retain high confidence predictions.
The remaining probabilities were then max-min scaled to derive edge scores on the scale 0.0 to 1.0.
In order to determine if the derived clusters reflected known physiological relationships, we tested the clusters for enrichment in
pathway annotations from the Reactome database (Fabregat et al., 2017). For the clusters with 10 or more kinases, we tested the
relative frequency of pathway annotations of the kinases assigned to the cluster relative to the frequency of those annotations for
the entire set of 504 kinases using the hypergeometric test as implemented by the ReactomePA package for R (Yu and He,
2016).We adjusted test p-values using the Benjamini-Hochbergmethod for controlling the false-discovery rate (Benjamini andHoch-
berg, 1995) and we set a critical value of 0.05 for testing significance. 315 kinases were annotated in Reactome V. 62 accessed
through reactome.db version 1.62.0 with 6151 pathway annotations altogether.
Pathway-Annotation Distances
We extracted the human protein-protein interaction network from IntAct (version: Oct. 2018) (Stutz et al., 2013). Additionally, on this
network, we integrated the human phosphorylation events extracted from SIGNOR, PhosphoSitePlus and OmniPath (T€urei et al.,
2016), resulting in a network containing 17089 nodes and 166757 edges. Given a pair of pathway annotations, we computed the
mean of all shortest path distances between the proteins annotated for the pair.
These distances were divided into two sets: distances between pathways that are enriched in the same cluster (n= 811) and dis-
tances between enriched pathways across clusters (n= 1019). Furthermore, we excluded distances between pathways that shared
kinases, which reduced our within-cluster set to 67. We used the Wilcoxon rank sum test to determine if there was a significant dif-
ference in distance between the two sets.
Network Modularity
To assess themodularity of our network we compared it to a set of randomly generated networks. Our reference network was gener-
ated by discarding all edges with probability lower than 0.5. The remaining edges were then min-max scaled to get an edge weight
distribution of values between 0 and 1. A set of randomized networks (n= 1000) with the same degree distribution as the reference
network were generated with the sample_degseq function in the igraph package. The ‘‘vl’’ method was used for network generation
(Viger and Latapy, 2005). At each randomization, the edge weights of the reference network were shuffled and assigned to the ran-
domized network. These were then clustered as described above. The modularity of the of the clustering was calculated with mod-












Wherem is the number of edges in the network, A is the adjacency matrix, k denotes the degree of the nodes in question and d is an
indicator function returning 0 if nodes i and j are both members of cluster c, and 1 otherwise. Applying this procedure to the random
networks provided us with an empirical distribution of modularity values from which we derived an empirical p-value for the modu-
larity of the reference network.
Prediction of Phosphosite Functional Sign
As a prerequisite for predicting the sign (activating versus inhibiting) of regulatory relationships, we first built a model to classify in-
dividual phosphosites as having either an inhibitory or activating effect on the substrate protein. As features, we used: the percentage
position of the site relative to the start and end of the protein kinase domain (i.e. between 0 and 1 for sites that fall within the domain);
the percentage position of the site along the protein’s length; the domain (if any) in which the phosphosite lies, including, but note6 Cell Systems 10, 384–396.e1–e9, May 20, 2020
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OPEN ACCESSArticlelimited to, protein kinase domains; the phosphosite residue (serine/threonine or tyrosine); whether or not the substrate is a tyrosine
kinase; an estimate of secondary sequence disorder, as calculated by DISOPRED (Ward et al., 2004); and the  log10p-value of the
site being in a phosphorylation hot-spot (Strumillo et al., 2019).
To train and validate our model, we fetched a list of human protein kinase phosphosites annotated as inducing or inhibiting activity
from PhosphoSitePlus (Hornbeck et al., 2015). We built our model using BART as described above. We evaluated model perfor-
mance via 20 iterations of 3-fold cross-validation on a training/validation set of 50 activating and 50 inhibiting phosphosites, sampled
randomly each iteration. The final model was trained using the full training set and posterior probabilities of a phosphosite being an
activating site were calculated.




where TA, TI, FA, and FI are the numbers of true activating, true inhibiting, false activating and false inhibiting predictions at a given
cutoff. Values above the cutoff were taken as ‘‘activating’’ predictions and those below were ‘‘inhibitory’’ predictions. The cutoff that
maximizes theMCCwas then subtracted from all predicted probabilities, yielding a score of less than zero for ‘‘inhibitory’’ predictions
and greater than zero for ‘‘activating’’ predictions. Finally, these scores were rescaled so that the largest absolute value was 1 while
maintaining a midpoint at zero.
Prediction of Regulatory Sign
We followed a similar procedure for classifying kinase-kinase regulatory relationships as being activating or inhibiting. The predictive
features that we used were: the regulator and substrate protein kinase types (serine/threonine versus tyrosine kinases); the signed
functional score; a signed formulation of the DCG; and a signed coregulation score. To derive a signed functional score, we simply
assigned the sign of the phosphosite sign prediction (negative for ‘‘inhibiting’’, positive for ‘‘activating’’) to the site’s functional score.
We then used the signed formulation of the substrate’s highest functional score as the final feature.
Signed Discounted Cumulative Gain
We modified the DCG calculation to determine whether a regulating kinase tends to ‘‘find’’ inhibitory or activating phosphosites on
the substrate kinase. To achieve this, we applied a DCG-like calculation to the signed functional scores, where a positive sum would
indicate an activating relationship and a negative sum would indicate an inhibitory one.
If the substrate phosphosites with the highest PSSM scores tend to have high functional scores with the same sign, the initial steps
of the DCG cumulative sum will move in one direction. However, if the substrate has many sites and the predicted signs of the sites
are unevenly distributed, the sheer number of sites alone would overcome the initial signal from the high PSSM-scoring sites. For
example, if the substrate has 3 predicted inhibitory sites which all have high PSSM scores for the regulator and 10 predicted acti-
vating sites that have low PSSM scores (but high functional scores), the final DCG on the signed functional scores would ultimately
be positive regardless of the site-ordering by PSSM. Thus, we formulated the signedDCG in terms of themost extreme value reached
by the sum.
We begin, as with the standard DCG, by ranking the n substrate sites according to decreasing PSSM scores (bs, as described
above). This produces an ordered set of their signed functional scores, F = fF1 ;F2 ;.;Fi ;.;Fn1;Fng. We then calculate a partial















We then normalize DCGagainst the most extreme value of the same sign possible for that substrate, retaining the sign. That is, if
DCG<0 we rank the substrate sites by increasing signed functional score to find DCGmin, the most extreme negative sum possible
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In order to produce a signed coregulation score, we followed the same procedure described above for the coregulation score. How-
ever, rather than using the p value of the correlation test, we used the signed correlation statistic (Spearman’s rho). In order to make
the test statistics comparable in spite of differing numbers of data points (i.e. number of conditions or samples in which two phos-







where n is the number of coquantified conditions/samples for the pair of sites and r is the estimated correlation coefficient. In order to
isolate correlations between likely regulatory sites, we then scaled z by the signed functional scores of the two sites. Finally, for a
given pair of protein kinases, we took the most extreme scaled z value as their signed coregulation score.
In calculating these signed coregulation scores, we encountered cases that are inconsistent with a direct regulatory relationship
between one protein kinase and another that is governed by a functional phosphosite on the regulator. In particular, in a direct reg-
ulatory relationship, the sign of the functional site on the regulator must be the same as the sign of the correlation. For example, if a
phosphosite on the regulator is inhibitory (negative), a positive correlation of phosphorylation state with a substrate functional site
could only occur through the activity of a third protein kinase (although we note that in kinases with more complicated rules of
multi-site regulation, such correlations might be possible). In order to better discriminate strong signals of coregulation, we therefore
removed site pairs in which the sign of the regulator’s site was incoherent with the sign of the correlation.
Training and Validation of the Sign Predictor
Webuilt a predictivemodel of regulatory sign from these features using BART as described above. As a training and validation set, we
used 503 signed regulatory relationships (394 activating, 109 inhibitory) between protein kinases from the OmniPath database that
were supported by at least two data sources. The model was validated via 20 iterations of 3-fold cross-validation, where each iter-
ation used a different random sample of 109 activating relationships for the training/validation set.
We built 20 iterations of the final model using similar random instantiations of the training set. Finally, for each directed kinase-ki-
nase pair, we assigned the mean posterior probability produced by these 20 models as a final regulatory sign score, where a higher
value would indicate an activating relationship and a lower score would predict an inhibitory relationship. For sign prediction in the
reconstruction of known pathways (Figure 5), we followed a similar ‘‘leave-one-out’’ procedure as described for prediction of the re-
lationships. For each kinase under consideration, we built 3 different models after removing all relationships including that kinase
from the training set. The mean posterior probability of each of that kinase’s relationships being ‘‘activating’’ from these 3 models
was used as the final prediction for the analysis.
Kinase Inhibitor Experiments
Phosphoproteomic analysis to test the predictions was carried out as described in Wilkes et al (Wilkes et al., 2015). Briefly, the Ka-
sumi-1 cell line, growing in RPMI medium supplemented with 10% FBS, was treated with 1mM trametinib or GDC-0941 for 1 h. Cells
were then lysed in a urea based lysis buffer. After trypsin digestion, phosphopeptides were enriched using TiO2 chromatography and
analyzed in a LS-MS/MS system consisting of an Ultimate 3000 ultra-high pressure chromatograph connected to a Q-Exactive Plus
mass spectrometer. Data analysis was performed using the Mascot search engine and Pescal as described (Wilkes et al., 2015).
Identification of Down-regulated Phosphosites
By analysing phosphoproteomic data treated with trametinib (MEKi) and GDC-0941(PI3Ki), we looked for phosphosites that were
down regulated by either inhibitor. We considered serine, threonine and tyrosine phosphorylated peptides even for multi-phosphor-
ylated peptides. We log2 transformed and quantile normalized the data to ensure that each sample followed the same distribution. To
identify phosphosites that were down-regulated in each condition, we used the limma function as implemented by the R package
limma (reproducibility-optimized statistical testing) (3.40.6)(Ritchie et al., 2015). Down-regulated phosphosites were selected by
applying the cutoff of log2 ratio to control of less than -1 and false discovery rate of lower than 0.1. p values were adjusted with
the Benjamini–Hochberg method.
Kinase-Substrate Shortest Paths
To see if any novel pathways could be established from the perturbed kinases, we looked for the shortest path from the kinases per-
turbed by trametinib (MAPK2K1 and MAP2K2) and GDC-0941 (PI3K) to phosphosites down-regulated by their perturbation. Since
PI3K is a lipid kinase we added edges between PI3K and kinases regulated by hsa:5290 (PIK3CA) and hsa:5291 (PIK3CB) and their
substrate, Phosphatidylinositol-3,4,5-trisphosphate, in the KEGG database (accessed 16 October, 2019)(Kanehisa, 2019; Kanehisa
and Goto, 2000; Kanehisa et al., 2019). Therefore, we added edges from PI3K to PRKCD (e.g. KEGG: hsa:04750), PRKCI (e.g KEGG:
hsa:04910), PRKCZ (e.g KEGG: hsa:04910), SRC (e.g. KEGG: hsa:04926), AKT1 (e.g. KEGG: hsa:04151), AKT2 (e.g. KEGG:
hsa:04151), ILK (e.g KEGG: hsa:04510), MTOR (e.g. KEGG: hsa:04150/hsa04910), PDPK1 (e.g. KEGG: hsa:04150), PDPK2 (e.g.
KEGG: hsa:04068), ITK (e.g KEGG: hsa:04062) and PTK2 (e.g. KEGG: hsa:04062) were added to the network.e8 Cell Systems 10, 384–396.e1–e9, May 20, 2020
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from PhosphoSitePlus (Hornbeck et al., 2015) were added to the network as well as interactions predicted by both the in vivo (Hijazi
et al., 2020) and in vitro (Sugiyama et al., 2019) experiments. Phosphosites that are known substrates of the perturbed kinases were
not considered for analysis. In the case of PI3K, substrates of kinases linked to PI3K were discarded as well. We removed all edges
with probability scores of less than 0.5. The function all_shortest_paths() as implemented in the R package igraph(Csárdi and Nepusz,
2006) was used to identify the shortest directed paths from the perturbed kinases to the phosphosites added to the network. The
parameter mode = ‘‘out’’ was used and the edge weights were calculated by subtracting the min-max scaled edge probabilities
from one. An interaction was considered novel if it was corroborated by either in vivo or in vitro experiment.
QUANTIFICATION AND STATISTICAL ANALYSES
All statistical tests and sample sizes are described in the Results section. Significance was determined at a significance level of 0.05.
The tests were carried out using the R statistical computing environment (R Core Team, 2016).
DATA AND CODE AVAILABILITY
The code generated during this study is available at GitHub (https://github.com/evocellnet/kinase-activity-net/). The published article
includes all other data generated during this study.Cell Systems 10, 384–396.e1–e9, May 20, 2020 e9
